#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16352	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2067	782.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1458	1458	C	921	C	891	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29500	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3666	802.1	0	.	n	.	0	T695C	SNP	695	695	T	1032	1032	C	943	C	888	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29500	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3666	802.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1674	1674	A	963	A	920	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29500	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3666	802.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2308	2308	C	901	C,T	855,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29500	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3666	802.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2382	2382	A	957	A	925	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29500	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3666	802.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2934	2934	C	867	C	837	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2148	folP	852	852	100.0	folP.l15.c4.ctg.1	1612	132.2	1	SNP	p	R228S	1	.	.	682	684	AGC	950	952	AGC	225;222;222	A;G;C	211;209;207	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5174	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3450	149.3	1	SNP	p	S91F	0	.	.	271	273	TCC	604	606	TCC	170;170;174	T;C;C	162;162;163	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5174	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3450	149.3	1	SNP	p	D95G	0	.	.	283	285	GAC	616	618	GAC	175;176;178	G;A;C	165;163;166	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5174	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3450	149.3	1	SNP	p	D95N	0	.	.	283	285	GAC	616	618	GAC	175;176;178	G;A;C	165;163;166	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1644	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1370	119.4	0	.	p	.	0	A39T	NONSYN	115	117	GCC	455	457	ACC	186;185;183	A;C;C,A	178;179;175,1	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1644	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1370	119.4	0	.	p	.	0	R44H	NONSYN	130	132	CGC	470	472	CAC	178;181;180	C;A;C	172;174;176	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1644	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1370	119.4	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	653	655	CAC	209;209;208	C,T;A;C	199,1;199;200	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1644	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1370	119.4	1	SNP	p	G45D	0	.	.	133	135	GGC	473	475	GGC	180;182;183	G;G;C	176;177;176	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	922	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c30.ctg.1	1125	81.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5374	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2945	181.7	1	SNP	p	D86N	0	.	.	256	258	GAC	597	599	GAC	207;207;208	G;A;C	200;196;203	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5374	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2945	181.7	1	SNP	p	S87W	0	.	.	259	261	AGT	600	602	AGT	209;210;210	A;G;T	203;203;199	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5374	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2945	181.7	1	SNP	p	S87I	0	.	.	259	261	AGT	600	602	AGT	209;210;210	A;G;T	203;203;199	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5374	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2945	181.7	1	SNP	p	S87R	0	.	.	259	261	AGT	600	602	AGT	209;210;210	A;G;T	203;203;199	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5374	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2945	181.7	1	SNP	p	S88P	0	.	.	262	264	TCC	603	605	TCC	210;211;214	T;C,G;C	202;202,1;207	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4436	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2820	156.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1612	1614	GGC	235;232;230	G;G;C	219;215;215	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4138	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2374	173.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1248	1250	GCA	224;221;220	G;C,G;A	210;201,1;207	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4138	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2374	173.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1251	1253	ATC	226;228;231	A;T;C	211;215;217	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4138	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2374	173.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1263	1265	GTG	234;232;233	G;T;G	225;217;220	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4138	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2374	173.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1263	1265	GTG	234;232;233	G;T;G	225;217;220	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4138	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2374	173.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1767	1769	ACC	196;194;193	A;C;C	187;188;188	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4138	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2374	173.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1821	1823	GCG	180;176;175	G;C;G	162;151;150	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4138	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2374	173.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1821	1823	GCG	180;176;175	G;C;G	162;151;150	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4138	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2374	173.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1944	1946	GGC	175;174;176	G;G;C,T	160;157;159,1	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4138	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2374	173.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1953	1955	GGC	176;173;174	G;G;C	159;154;154	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4138	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2374	173.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1971	1973	CCG	143;149;151	C,A,G;C;G	116,1,1;123;125	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	6110	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3232	188.2	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1774	1776	CTG	210;212;215	C;T;G	183;191;190	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2196	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1933	113.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	567	567	C	152	C	141	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3182	porB1b	1038	1038	97.3	porB1b.l6.c4.ctg.1	1597	198.1	0	.	p	.	0	I45V	NONSYN	133	135	ATT	481	483	GTT	263;264;264	G,A;T;T	249,2;251;253	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3182	porB1b	1038	1038	97.3	porB1b.l6.c4.ctg.1	1597	198.1	0	.	p	.	0	G48E	NONSYN	142	144	GGA	490	492	GAA	277;279;286	G;A,G;A	264;264,1;271	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3182	porB1b	1038	1038	97.3	porB1b.l6.c4.ctg.1	1597	198.1	0	.	p	.	0	I75V	NONSYN	223	225	ATT	571	573	GTT	276;277;276	G;T;T	265;264;261	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3182	porB1b	1038	1038	97.3	porB1b.l6.c4.ctg.1	1597	198.1	0	.	p	.	0	S89T	NONSYN	265	267	AGC	613	615	ACC	254;253;257	A;C,G;C,T	228;237,1;242,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3182	porB1b	1038	1038	97.3	porB1b.l6.c4.ctg.1	1597	198.1	0	.	p	.	0	I98V	NONSYN	292	294	ATC	640	642	GTC	248;243;243	G,A;T;C	230,1;226;227	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3182	porB1b	1038	1038	97.3	porB1b.l6.c4.ctg.1	1597	198.1	0	.	p	.	0	A109V	NONSYN	325	327	GCC	673	675	GTC	224;223;225	G;T,C;C	212;201,1;210	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3182	porB1b	1038	1038	97.3	porB1b.l6.c4.ctg.1	1597	198.1	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	739	741	TAT	224;225;228	T;A;T	210;213;216	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3182	porB1b	1038	1038	97.3	porB1b.l6.c4.ctg.1	1597	198.1	0	.	p	.	0	N134E	NONSYN	400	402	AAT	748	750	GAG	232;234;240	G;A;G	219;218;224	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3182	porB1b	1038	1038	97.3	porB1b.l6.c4.ctg.1	1597	198.1	0	.	p	.	0	V135F	NONSYN	403	405	GTG	751	753	TTT	238;239;244	T;T;T	220;224;227	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3182	porB1b	1038	1038	97.3	porB1b.l6.c4.ctg.1	1597	198.1	0	.	p	.	0	G140K	NONSYN	418	420	GGA	766	768	AAA	252;254;254	A;A;A	236;240;239	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3182	porB1b	1038	1038	97.3	porB1b.l6.c4.ctg.1	1597	198.1	0	.	p	.	0	Q143G	NONSYN	427	429	CAA	775	777	GGA	245;244;247	G,A;G;A	235,1;235;232	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3182	porB1b	1038	1038	97.3	porB1b.l6.c4.ctg.1	1597	198.1	0	.	p	.	0	M254I	NONSYN	760	762	ATG	1108	1110	ATA	259;258;260	A;T,A;A,G	257;257,1;259,1	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11848	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4949	238.7	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2053	2055	AAT	262;258;258	A;A;T	252;249;246	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1356	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1194	113.1	1	SNP	p	V57M	1	.	.	169	171	ATG	610	612	ATG	272;275;274	A;T;G	258;260;259	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
